Welcome to our dedicated page for CANSORTIUM news (Ticker: CNTMF), a resource for investors and traders seeking the latest updates and insights on CANSORTIUM stock.
Cansortium Inc (CNTMF) is a leading multi-state operator in the cannabis sector, focusing on cultivation, processing, and dispensing high-quality medical and recreational cannabis products. With a strong presence in key markets like Florida, New York, and Pennsylvania, Cansortium is dedicated to providing patients and consumers with innovative and effective cannabis solutions. The company's robust financial position, strategic partnerships, and commitment to compliance and sustainability set it apart in the industry.
Cansortium (CSE: TIUM.U, OTCQB: CNTMF) and RIV Capital (CSE: RIV, OTC: CNPOF) announced a definitive agreement for a business combination. Under this Arrangement Agreement, Cansortium will acquire all outstanding shares of RIV Capital. Shareholders of Cansortium will own approximately 51.25% of the combined entity, while RIV Capital shareholders and The Hawthorne Collective will hold 48.75%. The merger will enhance the combined company's presence in Florida, New York, Texas, and Pennsylvania and aims to eliminate $175 million of debt. The combined entity will have a pro forma cash balance of $74 million, with anticipated annual cost synergies of $5-10 million. The transaction is expected to close in Q4 2024, subject to regulatory and shareholder approvals.
Cansortium, operating under the FLUENT brand, announced a change in its Chief Financial Officer (CFO) position. Jeffrey Batliner resigned as CFO effective May 13, 2024. Patricia Fonseca has been re-appointed as the CFO, effective immediately. Ms. Fonseca previously served as the company's CFO from March 9, 2021, to November 21, 2022.
The company and its board of directors expressed gratitude to Mr. Batliner for his contributions and extended best wishes for his future endeavors.
Cansortium Inc. reported strong financial results for Q4 and full year 2023, with record revenue, positive cash flow, and growth in key markets. Revenue increased 9% YoY to $25.5 million in Q4 and 11% to $97.3 million for the full year. Adjusted gross profit was $49.5 million, with $27.2 million in adjusted EBITDA for the year. The Company remains focused on operational improvements, expansion in Florida and Pennsylvania, and growth in Texas.
FAQ
What is the current stock price of CANSORTIUM (CNTMF)?
What is the market cap of CANSORTIUM (CNTMF)?
What is Cansortium Inc's primary focus?
In which key markets does Cansortium operate?
What sets Cansortium apart in the cannabis industry?
How can investors get in touch with Cansortium's CEO?
Where can investors find more information about Cansortium Inc?
What is Cansortium's outstanding debt composition?
What is the cash position net of debt for Cansortium Inc?
How does Cansortium calculate adjusted gross profit?
What drives Cansortium's success in the cannabis industry?